Clinigence Holdings, Inc. reported unaudited impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported goodwill impairment of $408,466,575.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6309 USD | -4.41% | -7.19% | -90.14% |
09/05 | Earnings Flash (NUTX) NUTEX HEALTH Posts Q1 Revenue $67.5M | MT |
09/05 | Nutex Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.23% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- NUTX Stock
- NUTX Stock
- News Nutex Health Inc.
- Clinigence Holdings, Inc. Reports Unaudited Impairment Charges for the Third Quarter Ended September 30, 2022